Diabetes |
Blood Sugar; Diabetes Mellitus; Non-Insulin Dependent Diabetes Mellitus; Type II Diabetes |
Clinical Trial: Internet Diabetes Self-Management
This study is not yet open for patient recruitment.
Verified by Stanford University September 2005
Purpose
The purpose of this study is to determine of the effectiveness of an Internet based Diabetes Self-Management workshop for people with type II diabetes. Half of the people who complete the workshop will be invited to continue their education by participating in a email discussion group. Thus, we will be able to learn both the efficacy of the original program as well as its efficacy when reinforced by the discussion group.
Diabetes is a disease that must be managed day by day by the individual with the disease. Although we know a great deal about the self-management of type II diabetes, most self-management is less than optimal. In addition, most people with diabetes do not have an opportunity to participate in formal diabetes education. This study will determine if an Internet delivered educational workshop will help people with diabetes manage their disease. Thus we will be measuring changes in behaviors, changes in symptoms and changes in HbA1c, blood pressure, cholesterol, and weight. If successful the workshop will serve as a prototype for Internet diabetes education.
| Condition | Intervention | Phase |
|---|---|---|
| diabetes type 2 | Behavior: Internet Diabetes Self-Management Program | Phase II |
MedlinePlus related topics: Diabetes
Study Type: Interventional
Study Design: Educational/Counseling/Training, Randomized, Open Label, Placebo Control, Crossover Assignment, Efficacy Study
Official Title: Internet Diabetes Self-Management: A Randomized Trial
Secondary Outcomes: non-HDL cholesterol index; Health-related quality of life; Health behaviors; Health care utilization
Expected Total Enrollment: 775
Study start: November 2005; Expected completion: June 2009
Last follow-up: December 2008; Data entry closure: February 2009
Eligibility
Inclusion Criteria:
Diabetes type 2 Have internet access and email address Live in the United States 18 years of age or older
Exclusion Criteria:
Previous participation in similar online or community-based self-management program Active treatment for cancer Pregnant
Location and Contact Information
Kathryn L Plant, MPH 650-723-7935 diabetes@med.stanford.edu
California
Leland Stanford Junior University, Department of Medicine, Palo Alto, California, 94305, United States
Kate Lorig, DrPH, Principal Investigator, Stanford University Department of Medicine
Diana D Laurent, MPH, Study Director, Stanford University Department of Medicine
More Information
Last Updated: September 15, 2005
Record first received: September 9, 2005
ClinicalTrials.gov Identifier: NCT00185601
Health Authority: United States: Institutional Review Board
ClinicalTrials.gov processed this record on 2005-09-20

Not Signed In -


